Skip to content

新市场公司

US · NEU #1616 按市值排名 上市于 1970
876.01 -11.81 -1.33%
实时 - 追踪5344个代码 - 心跳于105秒前 · 2026-10-16 19:30

✦ 量化合理价值 计算方式说明

高于合理价值
548.21 合理价值 ≈ 649.62 751.04
  • 基于该股自身过去5年平均市盈率乘以滚动每股收益,推算出的合理价值区间为548.21-751.04。
  • 当前价格比按平均倍数计算的合理价值(649.62)高34.8%。

估值 各估值倍数与自身5年区间的对比

市净率 4.62 高于历史水平 第71百分位
5年平均 4.38 · 在Specialty Chemicals中排名第47/56
市盈率 19.88 高于历史水平 第99百分位
5年平均 14.62 · 在Specialty Chemicals中排名第9/32
市销率 3.10 高于历史水平 第99百分位
5年平均 1.87 · 在Specialty Chemicals中排名第48/61

同业对比 Specialty Chemicals

公司 市值 市盈率(TTM) 市净率 股息率
新市场公司 (NEU) 8.06B 18.85 4.38 1.34%
Linde (LIN) 229.77B 32.16 5.88 1.24%
Sherwin-Williams (SHW) 81.37B 30.92 21.11 0.95%
Ecolab (ECL) 80.98B 38.78 8.05 0.98%
Air Products & Chemicals (APD) 66.71B -1,426.62 4.81 2.40%
PPG Industries (PPG) 23.87B 15.36 2.83 2.64%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★★☆☆ 合理价值923.59 经济护城河Narrow 不确定性High

当前股价低于晨星合理价值估算5.4%。

合理价值

NewMarket Corp earns a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a price consistent with our quantitative fair value estimate, which has a high uncertainty rating.

The company's valuation metrics undermine our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 21.6% lies in the bottom 20% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our balanced fair value estimate.

The company's balance sheet is an additional cause for concern. Low leverage can limit a company's ability to invest in growth, potentially reducing shareholder value compared with a balanced use of debt and equity financing. The firm's EBITDA/interest coverage ratio of 20.5, for example, lies in the top 45% compared with peers globally. The company may have too conservative of a balance sheet based on its high EBITDA/interest coverage ratio, potentially underinvesting in growth opportunities and undermining the long-term trajectory of cash flows. This characteristic further promotes our neutral price/fair value ratio.

经济护城河

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

作者:Quantitative Equity Report

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

新市场公司 讨论区 0 条评论

发表评论